AtaGenix Laboratories

Featured Technical Services

Solution

  • Recombinant Protein Expression

  • Custom Antibody Discovery

  • Antibody Engineering & Applications

  • Antibody Production

  • Featured Products

Recombinant Protein Expression

More >
Mammalian Cell Protein Expression Service – Efficient and High-Quality Customized Protein Solutions

AtaGenix offers professional mammalian cell protein expression services, specializing in foundational research, drug development, and diagnostic reagent production. We excel in efficiently producing high-quality recombinant proteins with natural post-translational modifications.

  • High Expression Efficiency: Utilizing optimized expression systems, we achieve efficient protein production, catering to diverse production scales.
  • Natural Post-Translational Modifications: Mammalian cell systems enable natural post-translational modifications such as glycosylation and phosphorylation, preserving the biological activity of the proteins.
  • Flexible Customization Services: Tailored to meet specific client requirements, we offer a wide range of expression vectors, tags, and purification strategies to ensure the final produc
More >
Mammalian Cell Protein Expression Services – Efficient, High-Quality, and Customized Protein Solutions

AtaGenix offers professional mammalian cell protein expression services, specializing in basic research, drug development, and diagnostic reagent production. We deliver high-quality recombinant proteins with natural post-translational modifications through efficient expression systems.

More >
XtenCHO™ High-Density Transient Expression System Services

AtaGenix offers the XtenCHO™ High-Density Transient Transfection Expression System, specifically designed for efficient protein and antibody production. This system features high expression levels, excellent cell viability, and cost-effectiveness, making it suitable for large-scale antibody and protein production needs across research and industrial applications. The XtenCHO™ cells are genetically optimized to enable efficient and stable antibody expression, providing reliable support for high-throughput experiments and industrial-scale production.

More >
Prokaryotic Protein Expression Services, Efficient and Cost-Effective Research Support

AtaGenix provides professional prokaryotic protein expression services, tailored for basic research and protein engineering. The service includes project evaluation, vector construction, protein purification, and quality testing. The prokaryotic system offers advantages such as high yield and cost efficiency. This service is applicable to enzyme engineering, drug target research, and antibody development, supporting scientific research efforts.

More >
Insect Cell/Baculovirus Protein Expression Services – Providing Efficient and Reliable Research Support

AtaGenix specializes in insect cell/baculovirus protein expression services, offering efficient expression of complex macromolecular proteins with natural post-translational modifications. This system serves as an ideal alternative to mammalian cells. We provide comprehensive support from project evaluation to quality testing, widely applied in basic research, vaccine development, virology, and drug screening.

More >
Mammalian Cell Protein Expression Services – Efficient and High-Quality Customized Protein Solutions

AtaGenix provides professional mammalian cell protein expression services, specializing in basic research, drug development, and diagnostic reagent production. We efficiently express high-quality recombinant proteins with natural post-translational modifications.

More >

Custom Antibody Discovery

Accelerating the R&D process comprehensively, from early discovery to clinical studies

More >

Antibody Engineering & Applications

From early discovery to clinical studies, accelerating the R&D process comprehensively

More >

Antibody Production

From early discovery to clinical studies, accelerating the R&D process comprehensively

More >

Featured Products

More >

Literature & News

Research Publishing

News

Industry News

About AtaGenix

Ask us